Clinical investigation of 145 cases of chronic lymphocytic leukemia in Japan

Oncology Reports

Volumn 3, Issue 3, 1996, Pages 477-482

  Suzuki, Kenshi ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

CLL in Japan; Prognosis

Indexed keywords

CLADRIBINE; CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEMBRANE ANTIGEN; PENTOSTATIN;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; FEMALE; HUMAN; JAPAN; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030000750     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.3.477     Document Type: Article

References (2)

1. Bennett JM, Catovsky D, Daniel MT, Francrin G, Galton DAG, Gralnic HR, et al: Proposals for three classifications of chronic (mature) B and T lymphoid classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 42: 567-584,1989.
2. Keating MJ, Kantarjian H, O'Brien S, Koller C, Talpaz M, Schachner J, el al: Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J Clin Oncol 9:44-49, 1991.